Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Plasma Biotal is a specialized contract manufacturing organization (CMO) and biomaterials company focused on the medical device industry. The company is a global leader in the production of high-purity Hydroxyapatite (HA) and the application of bioactive plasma-sprayed coatings for orthopedic and dental implants. Their core product line, Captal®, includes various forms of HA powders and granules used to enhance the biological fixation of implants to bone. In 2021, Plasma Biotal was acquired by Eurofins Scientific, becoming part of the Eurofins Medical Device Testing network to provide integrated manufacturing and analytical services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Plasma Biotal.